National Health Investors, Inc. (NHI) Upgraded by ValuEngine to “Buy”

ValuEngine upgraded shares of National Health Investors, Inc. (NYSE:NHI) from a hold rating to a buy rating in a research report released on Friday.

Other analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of National Health Investors from a hold rating to a buy rating and set a $86.00 target price on the stock in a report on Friday. BidaskClub downgraded shares of National Health Investors from a hold rating to a sell rating in a report on Wednesday, August 9th. BMO Capital Markets restated a hold rating and set a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. Finally, Stifel Nicolaus restated a buy rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of $80.14.

National Health Investors (NHI) traded up $0.23 during trading on Friday, reaching $76.66. 223,200 shares of the company traded hands, compared to its average volume of 192,348. National Health Investors has a twelve month low of $67.33 and a twelve month high of $81.21. The company has a market cap of $3,183.84, a price-to-earnings ratio of 14.71, a price-to-earnings-growth ratio of 3.79 and a beta of 0.58. The company has a quick ratio of 12.45, a current ratio of 12.72 and a debt-to-equity ratio of 0.84.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a return on equity of 12.74% and a net margin of 59.70%. The firm had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same period in the previous year, the business earned $1.22 EPS. The firm’s revenue was up 14.1% compared to the same quarter last year. research analysts anticipate that National Health Investors will post 5.25 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.chaffeybreeze.com/2017/11/12/national-health-investors-inc-nhi-upgraded-by-valuengine-to-buy.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be issued a $0.95 dividend. The ex-dividend date is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.96%. National Health Investors’s dividend payout ratio (DPR) is presently 95.00%.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now directly owns 21,228 shares in the company, valued at $1,693,994.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 5.19% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. Schwab Charles Investment Management Inc. increased its holdings in National Health Investors by 9.7% during the first quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock worth $11,716,000 after buying an additional 14,297 shares during the last quarter. BlackRock Inc. increased its holdings in National Health Investors by 6,473.4% during the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Prudential Financial Inc. increased its holdings in National Health Investors by 137.4% during the second quarter. Prudential Financial Inc. now owns 13,683 shares of the real estate investment trust’s stock worth $1,084,000 after buying an additional 7,920 shares during the last quarter. Tocqueville Asset Management L.P. increased its holdings in National Health Investors by 2.3% during the second quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock worth $348,000 after buying an additional 100 shares during the last quarter. Finally, Good Life Advisors LLC acquired a new position in National Health Investors during the second quarter worth $282,000. Institutional investors and hedge funds own 70.13% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply